Roberts Glore & CO Inc Amgen Inc Transaction History

Roberts Glore & CO Inc

$328 Million
Q2 2024

A detailed history of Roberts Glore & CO Inc transactions in Amgen Inc stock. As of the latest transaction made, Roberts Glore & CO Inc holds 7,968 shares of AMGN stock, worth $2.54 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

7,968

Previous 8,327 4.31%

Holding current value

$2.54 Million

Previous $2.37 Million 5.15%

% of portfolio

0.76%

Previous 0.72%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $94,327 - $114,632	-359 Reduced 4.31%	7,968 $2.49 Million
Q1 2024 May 09, 2024	SELL	$268.87 - $324.56 $35,490 - $42,841	-132 Reduced 1.56%	8,327 $2.37 Million
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $9,205 - $10,384	-36 Reduced 0.42%	8,459 $2.44 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $5,466 - $6,786	-25 Reduced 0.29%	8,495 $2.28 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $1,714 - $2,026	8 Added 0.09%	8,520 $1.89 Million
Q1 2023 May 08, 2023	SELL	$225.79 - $275.2 $9,257 - $11,283	-41 Reduced 0.48%	8,512 $2.06 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $251,933 - $320,111	-1,100 Reduced 11.4%	8,553 $2.25 Million
Q3 2022 Nov 07, 2022	SELL	$224.46 - $253.15 $33,220 - $37,466	-148 Reduced 1.51%	9,653 $2.18 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $5,306 - $5,905	-23 Reduced 0.23%	9,801 $2.39 Million
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $14,252 - $15,767	-65 Reduced 0.66%	9,824 $2.38 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $8,551 - $9,786	-43 Reduced 0.43%	9,889 $2.23 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $4,669 - $5,471	-22 Reduced 0.22%	9,932 $2.11 Million
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $11,679 - $12,957	-50 Reduced 0.5%	9,954 $2.43 Million
Q3 2020 Nov 06, 2020	SELL	$234.65 - $260.95 $5,396 - $6,001	-23 Reduced 0.23%	10,004 $2.54 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $13,055 - $16,020	-66 Reduced 0.65%	10,027 $2.36 Million
Q1 2020 May 11, 2020	SELL	$182.24 - $241.7 $2,733 - $3,625	-15 Reduced 0.15%	10,093 $2.05 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $666,776 - $857,036	3,524 Added 53.52%	10,108 $2.44 Million
Q3 2019 Nov 08, 2019	SELL	$174.11 - $208.62 $3,830 - $4,589	-22 Reduced 0.33%	6,584 $1.27 Million
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $4,883 - $5,504	-27 Reduced 0.41%	6,606 $1.26 Million
Q4 2018 Feb 08, 2019	SELL	$178.4 - $208.25 $38,891 - $45,398	-218 Reduced 3.18%	6,633 $1.29 Million
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $1,297 - $1,462	-7 Reduced 0.1%	6,851 $1.42 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $498 - $559	-3 Reduced 0.04%	6,858 $1.27 Million
Q1 2018 May 08, 2018	SELL	$169.43 - $198.0 $6,777 - $7,920	-40 Reduced 0.58%	6,861 $1.17 Million
Q4 2017 Feb 09, 2018	SELL	$168.79 - $188.59 $40,003 - $44,695	-237 Reduced 3.32%	6,901 $1.2 Million
Q3 2017 Nov 08, 2017	SELL	$167.29 - $191.0 $48,012 - $54,817	-287 Reduced 3.87%	7,138 $1.33 Million
Q2 2017 Aug 15, 2017	BUY	N/A	7,425	7,425 $1.28 Million

Others Institutions Holding AMGN

# of Institutions

3,090

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.13M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roberts Glore & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Roberts Glore & CO Inc with notifications on news.

Account

Roberts Glore & CO Inc Amgen Inc Transaction History